Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Effectiveness of Pulmonary Rehabilitation in Severe Asthma - a Retrospective Data Analysis.

Zampogna E, Centis R, Negri S, Fiore E, Cherubino F, Pignatti P, Heffler E, Canonica GW, Sotgiu G, Saderi L, Migliori GB, Spanevello A, Visca D.

J Asthma. 2019 Jul 18:1-12. doi: 10.1080/02770903.2019.1646271. [Epub ahead of print]

PMID:
31317799
2.

Effectiveness of a Pulmonary Rehabilitation Program on Persistent Asthma Stratified for Severity.

Zampogna E, Paneroni M, Cherubino F, Pignatti P, Rudi M, Casu G, Vitacca M, Spanevello A, Visca D.

Respir Care. 2019 Jul 16. pii: respcare.06761. doi: 10.4187/respcare.06761. [Epub ahead of print]

PMID:
31311850
3.

Do blood eosinophils strictly reflect airway inflammation in COPD? Comparison with asthmatic patients.

Pignatti P, Visca D, Cherubino F, Zampogna E, Lucini E, Saderi L, Sotgiu G, Spanevello A.

Respir Res. 2019 Jul 10;20(1):145. doi: 10.1186/s12931-019-1111-1.

4.

Minimum Clinically Important Difference in 30-s Sit-to-Stand Test After Pulmonary Rehabilitation in Subjects With COPD.

Zanini A, Crisafulli E, D'Andria M, Gregorini C, Cherubino F, Zampogna E, Azzola A, Spanevello A, Schiavone N, Chetta A.

Respir Care. 2019 Jul 3. pii: respcare.06694. doi: 10.4187/respcare.06694. [Epub ahead of print]

PMID:
31270178
5.

Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study.

Contoli M, Baraldo S, Conti V, Gnesini G, Marku B, Casolari P, Scrigner P, Morelli P, Saetta M, Spanevello A, Papi A.

Respirology. 2019 Jun 28. doi: 10.1111/resp.13607. [Epub ahead of print]

PMID:
31251440
6.

[Linking the ICF codes to clinical real-life assessments: the challenge of the transition from theory to practice].

Giardini A, Vitacca M, Pedretti R, Nardone A, Chiovato L, Spanevello A.

G Ital Med Lav Ergon. 2019 May;41(2):78-104. Italian.

7.

Prioritizing research challenges and funding for allergy and asthma and the need for translational research-The European Strategic Forum on Allergic Diseases.

Agache I, Annesi-Maesano I, Bonertz A, Branca F, Cant A, Fras Z, Ingenrieth F, Namazova-Baranova L, Odemyr M, Spanevello A, Vieths S, Yorgancioglu A, Alvaro-Lozano M, Barber Hernandez D, Chivato T, Del Giacco S, Diamant Z, Eguiluz-Gracia I, van Wijk RG, Gevaert P, Graessel A, Hellings P, Hoffmann-Sommergruber K, Jutel M, Lau S, Lauerma A, Maria Olaguibel J, O'Mahony L, Ozdemir C, Palomares O, Pfaar O, Sastre J, Scadding G, Schmidt-Weber C, Schmid-Grendelmeier P, Shamji M, Skypala I, Spinola M, Spranger O, Torres M, Vereda A, Bonini S.

Allergy. 2019 May 9. doi: 10.1111/all.13856. [Epub ahead of print]

PMID:
31070805
8.

Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018.

Seys SF, Quirce S, Agache I, Akdis CA, Alvaro-Lozano M, Antolín-Amérigo D, Bjermer L, Bobolea I, Bonini M, Bossios A, Brinkman P, Bush A, Calderon M, Canonica W, Chanez P, Couto M, Davila I, Del Giacco S, Del Pozo V, Erjefält JS, Gevaert P, Hagedoorn P, G Heaney L, Heffler E, Hellings PW, Jutel M, Kalayci O, Kurowski MM, Loukides S, Nair P, Palomares O, Polverino E, Sanchez-Garcia S, Sastre J, Schwarze J, Spanevello A, Ulrik CS, Usmani O, Van den Berge M, Vasakova M, Vijverberg S, Diamant Z.

Allergy. 2019 Apr 25. doi: 10.1111/all.13843. [Epub ahead of print] No abstract available.

PMID:
31021446
9.

Adherence to Continuous Positive Airway Pressure in patients with Obstructive Sleep Apnoea. A ten year real life study.

Zampogna E, Spanevello A, Lucioni AM, Facchetti C, Sotgiu G, Saderi L, Ambrosino N, Visca D.

Respir Med. 2019 Apr;150:95-100. doi: 10.1016/j.rmed.2019.02.017. Epub 2019 Mar 1.

PMID:
30961958
10.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

Akkerman O, Aleksa A, Alffenaar JW, Al-Marzouqi NH, Arias-Guillén M, Belilovski E, Bernal E, Boeree MJ, Borisov SE, Bruchfeld J, Cadiñanos Loidi J, Cai Q, Caminero JA, Cebrian Gallardo JJ, Centis R, Codecasa LR, D'Ambrosio L, Dalcolmo M, Danila E, Dara M, Davidavičienė E, Davies Forsman L, De Los Rios Jefe J, Denholm J, Duarte R, Elamin SE, Ferrarese M, Filippov A, Ganatra S, Garcia A, García-García JM, Gayoso R, Giraldo Montoya AM, Gomez Rosso RG, Gualano G, Hoefsloot W, Ilievska-Poposka B, Jonsson J, Khimova E, Kuksa L, Kunst H, Laniado-Laborín R, Li Y, Magis-Escurra C, Manfrin V, Manga S, Marchese V, Martínez Robles E, Maryandyshev A, Matteelli A, Migliori GB, Mullerpattan JB, Munoz-Torrico M, Mustafa Hamdan H, Nieto Marcos M, Noordin NM, Palmero DJ, Palmieri F, Payen MC, Piubello A, Pontali E, Pontarelli A, Quirós S, Rendon A, Skrahina A, Šmite A, Solovic I, Sotgiu G, Souleymane MB, Spanevello A, Stošić M, Tadolini M, Tiberi S, Udwadia ZF, van den Boom M, Vescovo M, Viggiani P, Visca D, Zhurkin D, Zignol M; members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring.

Int J Infect Dis. 2019 Jun;83:72-76. doi: 10.1016/j.ijid.2019.03.036. Epub 2019 Apr 3.

11.

Research highlights from the 2018 European Respiratory Society International Congress: airway disease.

Schleich F, Bikov A, Mathioudakis AG, McDonnell M, Andersson C, Bonini M, Uller L, Idzko M, Singh D, Lopez-Campos JL, Bossios A, Adcock IM, Usmani O, Spanevello A, Bonvini SJ.

ERJ Open Res. 2019 Mar 18;5(1). pii: 00225-2018. doi: 10.1183/23120541.00225-2018. eCollection 2019 Feb. Review.

12.

Pulmonary rehabilitation is effective in patients with tuberculosis pulmonary sequelae.

Visca D, Zampogna E, Sotgiu G, Centis R, Saderi L, D'Ambrosio L, Pegoraro V, Pignatti P, Muňoz-Torrico M, Migliori GB, Spanevello A.

Eur Respir J. 2019 Mar 14;53(3). pii: 1802184. doi: 10.1183/13993003.02184-2018. Print 2019 Mar. No abstract available.

PMID:
30872556
13.

The new frontiers of rehabilitation medicine in people with chronic disabling illnesses.

Scrutinio D, Giardini A, Chiovato L, Spanevello A, Vitacca M, Melazzini M, Giorgi G.

Eur J Intern Med. 2019 Mar;61:1-8. doi: 10.1016/j.ejim.2018.10.019. Epub 2018 Oct 30. Review.

14.

Relationship between diabetes and respiratory diseases-Clinical and therapeutic aspects.

Visca D, Pignatti P, Spanevello A, Lucini E, La Rocca E.

Pharmacol Res. 2018 Nov;137:230-235. doi: 10.1016/j.phrs.2018.10.008. Epub 2018 Oct 9. Review.

PMID:
30312663
15.

Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018.

Satia I, Badri H, Lahousse L, Usmani OS, Spanevello A.

J Thorac Dis. 2018 Sep;10(Suppl 25):S2992-S2997. doi: 10.21037/jtd.2018.08.23. No abstract available.

16.

Small airway inflammation and extrafine inhaled corticosteroids plus long-acting beta2-agonists formulations in chronic obstructive pulmonary disease.

Pirina P, Foschino Barbaro MP, Paleari D, Spanevello A.

Respir Med. 2018 Oct;143:74-81. doi: 10.1016/j.rmed.2018.08.013. Epub 2018 Aug 28. Review.

17.

Is there a role for biomarkers in pulmonary rehabilitation?

Maniscalco M, Paris D, Carone M, Spanevello A, Vitacca M, Motta A.

Biomark Med. 2018 Oct;12(10):1069-1072. doi: 10.2217/bmm-2018-0219. Epub 2018 Sep 7. No abstract available.

PMID:
30191733
18.

Outcomes of patients with drug-resistant-tuberculosis treated with bedaquiline-containing regimens and undergoing adjunctive surgery.

Borisov SE, D'Ambrosio L, Centis R, Tiberi S, Dheda K, Alffenaar JW, Amale R, Belilowski E, Bruchfeld J, Canneto B, Denholm J, Duarte R, Esmail A, Filippov A, Davies Forsman L, Gaga M, Ganatra S, Igorevna GA, Lazaro Mastrapa B, Manfrin V, Manga S, Maryandyshev A, Massard G, González Montaner P, Mullerpattan J, Palmero DJ, Pontarelli A, Papavasileiou A, Pontali E, Romero Leyet R, Spanevello A, Udwadia ZF, Viggiani P, Visca D, Sotgiu G, Migliori GB.

J Infect. 2019 Jan;78(1):35-39. doi: 10.1016/j.jinf.2018.08.003. Epub 2018 Aug 7.

PMID:
30096332
20.

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review.

Pontali E, Sotgiu G, Tiberi S, Tadolini M, Visca D, D'Ambrosio L, Centis R, Spanevello A, Migliori GB.

Eur Respir J. 2018 Jul 4;52(1). pii: 1800934. doi: 10.1183/13993003.00934-2018. Print 2018 Jul. No abstract available.

PMID:
29903862
21.

Tuberculosis elimination: where are we now?

Matteelli A, Rendon A, Tiberi S, Al-Abri S, Voniatis C, Carvalho ACC, Centis R, D'Ambrosio L, Visca D, Spanevello A, Battista Migliori G.

Eur Respir Rev. 2018 Jun 13;27(148). pii: 180035. doi: 10.1183/16000617.0035-2018. Print 2018 Jun 30. Review.

22.

Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD.

Donner CF, Amaducci S, Bacci E, Baldacci S, Bartoli ML, Beghi GM, Benfante A, Brighindi S, Casali L, Castiglia D, Cazzola M, Celi A, Cianchetti S, Colombo G, Crimi C, Dente FL, Di Maria G, Di Maria A, Latorre M, Lavorini F, Maio S, Mannini C, Messina R, Paggiaro PL, Pignatti P, Price D, Scichilone N, Simoni M, Spanevello A, Stagno d'Alcontres M, Tan S, Torchio R, Viegi G, Visca D, Wouters EFM, Yu Hui Xin S.

Monaldi Arch Chest Dis. 2018 Feb 2;88(1):886. doi: 10.4081/monaldi.2018.886.

23.

Research highlights from the 2017 ERS International Congress: airway diseases in focus.

Andersson C, Bonvini SJ, Horvath P, Marquez E, Satia I, Kirkham P, Schleich F, Idzko M, Gosens R, Lopez-Campos JL, Bossios A, Usmani O, Spanevello A, Adcock IM, Mathioudakis AG.

ERJ Open Res. 2018 Mar 13;4(1). pii: 00163-2017. doi: 10.1183/23120541.00163-2017. eCollection 2018 Jan. Review.

24.

Multi and extensively drug-resistant pulmonary tuberculosis: advances in diagnosis and management.

Pontali E, Visca D, Centis R, D'Ambrosio L, Spanevello A, Migliori GB.

Curr Opin Pulm Med. 2018 May;24(3):244-252. doi: 10.1097/MCP.0000000000000477. Review.

PMID:
29470252
25.

Airway inflammatory phenotypes: Making sputum cell evaluation more accessible for clinical use.

Pignatti P, Visca D, Leoni V, Zampogna E, Cherubino F, Sotgiu G, Lucini E, Spanevello A.

Clin Respir J. 2018 May;12(5):1989-1990. doi: 10.1111/crj.12747. Epub 2017 Dec 21. No abstract available.

PMID:
29193790
26.

Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD.

Contoli M, Pauletti A, Rossi MR, Spanevello A, Casolari P, Marcellini A, Forini G, Gnesini G, Marku B, Barnes N, Rizzi A, Curradi G, Caramori G, Morelli P, Papi A.

Eur Respir J. 2017 Oct 5;50(4). pii: 1700451. doi: 10.1183/13993003.00451-2017. Print 2017 Oct.

27.

Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients.

Contoli M, Campo G, Pavasini R, Marchi I, Pauletti A, Balla C, Spanevello A, Ferrari R, Papi A.

Eur J Intern Med. 2018 Jan;47:82-86. doi: 10.1016/j.ejim.2017.08.016. Epub 2017 Aug 15.

PMID:
28821412
28.

Integrated care of chronic degenerative non-communicable diseases and rehabilitation: the odd couple?

Balbi B, Marcassa C, Pisani F, Corica G, Spanevello A.

Monaldi Arch Chest Dis. 2017 May 18;87(1):818. doi: 10.4081/monaldi.2017.818.

29.

Is bronchodilator the correct treatment for COPD subjects before EBUS?

Leoni V, Pignatti P, Visca D, Spanevello A.

J Thorac Dis. 2017 May;9(Suppl 5):S410-S413. doi: 10.21037/jtd.2017.03.142. Review.

30.

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.

Borisov SE, Dheda K, Enwerem M, Romero Leyet R, D'Ambrosio L, Centis R, Sotgiu G, Tiberi S, Alffenaar JW, Maryandyshev A, Belilovski E, Ganatra S, Skrahina A, Akkerman O, Aleksa A, Amale R, Artsukevich J, Bruchfeld J, Caminero JA, Carpena Martinez I, Codecasa L, Dalcolmo M, Denholm J, Douglas P, Duarte R, Esmail A, Fadul M, Filippov A, Davies Forsman L, Gaga M, Garcia-Fuertes JA, García-García JM, Gualano G, Jonsson J, Kunst H, Lau JS, Lazaro Mastrapa B, Teran Troya JL, Manga S, Manika K, González Montaner P, Mullerpattan J, Oelofse S, Ortelli M, Palmero DJ, Palmieri F, Papalia A, Papavasileiou A, Payen MC, Pontali E, Robalo Cordeiro C, Saderi L, Sadutshang TD, Sanukevich T, Solodovnikova V, Spanevello A, Topgyal S, Toscanini F, Tramontana AR, Udwadia ZF, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2017 May 21;49(5). pii: 1700387. doi: 10.1183/13993003.00387-2017. Print 2017 May.

31.

A European Respiratory Society technical standard: exhaled biomarkers in lung disease.

Horváth I, Barnes PJ, Loukides S, Sterk PJ, Högman M, Olin AC, Amann A, Antus B, Baraldi E, Bikov A, Boots AW, Bos LD, Brinkman P, Bucca C, Carpagnano GE, Corradi M, Cristescu S, de Jongste JC, Dinh-Xuan AT, Dompeling E, Fens N, Fowler S, Hohlfeld JM, Holz O, Jöbsis Q, Van De Kant K, Knobel HH, Kostikas K, Lehtimäki L, Lundberg J, Montuschi P, Van Muylem A, Pennazza G, Reinhold P, Ricciardolo FLM, Rosias P, Santonico M, van der Schee MP, van Schooten FJ, Spanevello A, Tonia T, Vink TJ.

Eur Respir J. 2017 Apr 26;49(4). pii: 1600965. doi: 10.1183/13993003.00965-2016. Print 2017 Apr.

32.

The Barthel index-dyspnea a tool for respiratory rehabilitation: reply to the letter by Chuang [Letter of clarification].

Carone M, Vitacca M, Paneroni M, Baiardi P, Spanevello A, Bertolotti G.

Int J Chron Obstruct Pulmon Dis. 2017 Mar 8;12:813-815. doi: 10.2147/COPD.S130991. eCollection 2017. No abstract available.

33.

Assembly 5: airway diseases: Meet the Assemblies.

Spanevello A.

Breathe (Sheff). 2017 Mar;13(1):59-60. doi: 10.1183/20734735.018516.

34.

Frequent coexistence of chronic heart failure and chronic obstructive pulmonary disease in respiratory and cardiac outpatients: Evidence from SUSPIRIUM, a multicentre Italian survey.

Griffo R, Spanevello A, Temporelli PL, Faggiano P, Carone M, Magni G, Ambrosino N, Tavazzi L; SUSPIRIUM Investigators.

Eur J Prev Cardiol. 2017 Apr;24(6):567-576. doi: 10.1177/2047487316687425. Epub 2017 Jan 9.

PMID:
28067533
35.

Classifying new anti-tuberculosis drugs: rationale and future perspectives.

Tiberi S, Scardigli A, Centis R, D'Ambrosio L, Muñoz-Torrico M, Salazar-Lezama MÁ, Spanevello A, Visca D, Zumla A, Migliori GB, Caminero Luna JA.

Int J Infect Dis. 2017 Mar;56:181-184. doi: 10.1016/j.ijid.2016.10.026. Epub 2016 Nov 3.

36.

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?

Muñoz-Torrico M, Rendon A, Centis R, D'Ambrosio L, Fuentes Z, Torres-Duque C, Mello F, Dalcolmo M, Pérez-Padilla R, Spanevello A, Migliori GB.

J Bras Pneumol. 2016 Sep-Oct;42(5):374-385. doi: 10.1590/S1806-37562016000000226. Review. English, Portuguese.

37.

Recent developments in the diagnosis and management of tuberculosis.

Sulis G, Centis R, Sotgiu G, D'Ambrosio L, Pontali E, Spanevello A, Matteelli A, Zumla A, Migliori GB.

NPJ Prim Care Respir Med. 2016 Nov 3;26:16078. doi: 10.1038/npjpcrm.2016.78. Review.

38.

Shortened questionnaires to assess anxiety and depression during in-hospital rehabilitation: clinical validation and cutoff scores.

Bertolotti G, Moroni L, Burro R, Spanevello A, Pedretti RF, Giorgetti G.

Neuropsychiatr Dis Treat. 2016 Oct 12;12:2627-2633. eCollection 2016.

39.

Towards a practical clinical use of fractioned exhaled nitric oxide levels in chronic cough.

Pignatti P, Spanevello A.

Ann Transl Med. 2016 Sep;4(18):357. No abstract available.

40.

Development of a Barthel Index based on dyspnea for patients with respiratory diseases.

Vitacca M, Paneroni M, Baiardi P, De Carolis V, Zampogna E, Belli S, Carone M, Spanevello A, Balbi B, Bertolotti G.

Int J Chron Obstruct Pulmon Dis. 2016 Jun 7;11:1199-206. doi: 10.2147/COPD.S104376. eCollection 2016.

41.

WHO strategies for the programmatic management of drug-resistant tuberculosis.

Matteelli A, Centis R, D'Ambrosio L, Sotgiu G, Tadolini M, Pontali E, Spanevello A, Migliori GB.

Expert Rev Respir Med. 2016 Sep;10(9):991-1002. doi: 10.1080/17476348.2016.1199278. Epub 2016 Jun 22. Review.

PMID:
27276361
42.

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Abdo Arbex M, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Auchynka V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2016 Jun;47(6):1758-66. doi: 10.1183/13993003.00214-2016. Epub 2016 Apr 13.

43.

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

Sotgiu G, D'Ambrosio L, Centis R, Tiberi S, Esposito S, Dore S, Spanevello A, Migliori GB.

Int J Mol Sci. 2016 Mar 12;17(3):373. doi: 10.3390/ijms17030373. Review.

44.

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Tiberi S, Payen MC, Sotgiu G, D'Ambrosio L, Alarcon Guizado V, Alffenaar JW, Abdo Arbex M, Caminero JA, Centis R, De Lorenzo S, Gaga M, Gualano G, Roby Arias AJ, Scardigli A, Skrahina A, Solovic I, Sulis G, Tadolini M, Akkerman OW, Alarcon Arrascue E, Aleska A, Avchinko V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2016 Apr;47(4):1235-43. doi: 10.1183/13993003.02146-2015. Epub 2016 Mar 10.

45.

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.

Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Arbex MA, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Avchinko V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Clin Infect Dis. 2016 May 1;62(9):1188-90. doi: 10.1093/cid/ciw088. Epub 2016 Feb 16. No abstract available.

PMID:
26908794
46.

The one repetition maximum test and the sit-to-stand test in the assessment of a specific pulmonary rehabilitation program on peripheral muscle strength in COPD patients.

Zanini A, Aiello M, Cherubino F, Zampogna E, Azzola A, Chetta A, Spanevello A.

Int J Chron Obstruct Pulmon Dis. 2015 Nov 11;10:2423-30. doi: 10.2147/COPD.S91176. eCollection 2015.

47.

The multidrug-resistant tuberculosis threat: old problems and new solutions.

Sotgiu G, D'Ambrosio L, Centis R, Mura I, Castiglia P, Spanevello A, Migliori GB.

J Thorac Dis. 2015 Sep;7(9):E354-60. doi: 10.3978/j.issn.2072-1439.2015.09.21. No abstract available.

48.

Management of drug resistantTB in patients with HIV co-infection.

Pontali E, Sotgiu G, Centis R, D'Ambrosio L, Spanevello A, Migliori GB.

Expert Opin Pharmacother. 2015;16(18):2737-50. doi: 10.1517/14656566.2015.1100169. Epub 2015 Oct 19. Review.

PMID:
26478945
49.

Efficacy and safety of surgical lung biopsy for interstitial disease. Experience of 161 consecutive patients from a single institution in Italy.

Rotolo N, Imperatori A, Dominioni L, Facchini A, Conti V, Castiglioni M, Spanevello A.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Sep 14;32(3):251-8.

PMID:
26422571
50.

Models of Respiratory Infections: Virus-Induced Asthma Exacerbations and Beyond.

Saturni S, Contoli M, Spanevello A, Papi A.

Allergy Asthma Immunol Res. 2015 Nov;7(6):525-33. doi: 10.4168/aair.2015.7.6.525. Epub 2015 Jul 7. Review.

Supplemental Content

Loading ...
Support Center